Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01643304
First received: July 16, 2012
Last updated: November 20, 2013
Last verified: November 2013

July 16, 2012
November 20, 2013
May 2012
Not Provided
Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01643304 on ClinicalTrials.gov Archive Site
  • Social consequences of heavy menstrual bleedings assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
  • Costs; e.g. pads, absence from work, loss of income assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
  • The treatments given for heavy menstrual bleedings, as surgery or medication assessed by questionnaire [ Time Frame: Once at baseline ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings
A Swedish Cross-sectional Study With Questionnaire to Investigate Perception of Menstrual Bleeding
This field based, questionnaire study will document observational data on womens perception of menstrual bleeding in a cross-section of women in Sweden. Each subject will complete the questionnaire at one occasion.
Not Provided
Observational
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Subjects included in the SIFO (Swedish institute of market research) volontary subject pool.
Menorrhagia
Behavioral: No drug
No drug intervention. The intervention is a questionnaire with quality of life and perception of menstrual bleedings. All subjects will complete both questionnaires.
Group 1
Intervention: Behavioral: No drug
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1547
June 2012
Not Provided

Inclusion Criteria:

  • All women 40-45 years available in the web-panel of SIFO
  • Completion of the web-based questionnaire

Exclusion Criteria:

Female
40 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01643304
16384, NN1223SE
No
Not Provided
Not Provided
Bayer
Bayer
Not Provided
Study Director: Bayer Study Director Bayer
Bayer
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP